Candriam S.C.A. Applied Therapeutics Inc. Transaction History

Candriam S.C.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Oct 19, 2020	SELL	$19.43 - $35.36 $1.55 Million - $2.83 Million	-80,000 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$29.41 - $51.23 $2.35 Million - $4.1 Million	80,000 New	80,000 $2.89 Million

139

114M

1.62M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $446M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.